Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae: Characterization of South African isolates

Journal of Antimicrobial Chemotherapy

Volumn 42, Issue 6, 1998, Pages 729-734

  Klugman, K P ^a,c   Capper, T ^a   Widdowson, C A ^a   Koornhof, H J ^a   Moser, W ^b  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b NOVARTIS PHARMA AG   (Switzerland)

^c NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; ERYTHROMYCIN; JOSAMYCIN; LACTONE DERIVATIVE; MACROLIDE; ROXITHROMYCIN; SPIRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CROSS RESISTANCE; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC RESISTANCE; NONHUMAN; SOUTH AFRICA; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; ERYTHROMYCIN; GENES, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PNEUMOCOCCAL INFECTIONS; SOUTH AFRICA; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 0032441416     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/42.6.729     Document Type: Article

References (26)

1. Istre, G. R., Welch, D. F., Marks, M. I. & Moyer, N. (1981). Susceptibility of group A β-hemolytic Streptococcus isolates to penicillin and erythromycin. Antimicrobial Agents and Chemotherapy 20, 244-6.
2. Chin, N.-X., Neu, N. M., Labthavikul, P., Saha, G. & Neu, H. C. (1987). Activity of A-56268 compared with that of erythromycin and other oral agents against aerobic and anaerobic bacteria. Antimicrobial Agents and Chemotherapy 31, 463-6.
3. Doern, G. V., Brueggemann, A., Holley, H. P. & Rauch, A. M. (1996). Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrobial Agents and Chemotherapy 40, 1208-13.
4. Hardy, D. J., Hensey, D. M., Beyer, J. M., Vojtko, C., McDonald, E. J. & Fernandes, P. B. (1988). Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides. Antimicrobial Agents and Chemotherapy 32, 1710-9.
5. Visalli, M. A., Jacobs, M. R. & Appelbaum, P. C. (1997). Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin and clindamycin. Antimicrobial Agents and Chemotherapy 41, 1867-70.
6. Seppälä, H., Nissinen, A., Yu, Q. & Huovinen, P. (1993). Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. Journal of Antimicrobial Chemotherapy 32, 885-91.
7. Lister, P. D. (1995). Multiply-resistant pneumococcus: therapeutic problems in the management of serious infections. European Journal of Clinical Microbiology and Infectious Diseases 14, Suppl. 1, S18-25.
8. Emond, J. P., Fremaux, A., Dublanchet, A., Sissia, G., Geslin, P., Sedalian, A. et al. (1989). Resistance of two strains of Streptococcus pneumoniae to pristinamycin associated with 16-membered macrolides. Pathologie Biologie 37, 791-2.
9. Leclercq, R. & Courvalin, P. (1991). Intrinsic and unusual resistance to macrolide, lincosamide and streptogramin antibiotics in bacteria. Antimicrobial Agents and Chemotherapy 35, 1273-6.
10. Sutcliffe, J., Tait-Kamradt, A. & Wondrack, L. (1996). Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrobial Agents and Chemotherapy 40, 1817-24.
11. National Committee for Clinical Laboratory Standards. (1995). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: Standard M7-A3. NCCLS, Villanova, PA.
12. Sutcliffe, J., Grebe, T., Tait-Kamradt, A. & Wondrack, L (1996). Detection of erythromycin-resistant determinants by PCR. Antimicrobial Agents and Chemotherapy 40, 2562-6.
13. Seppälä, H., Klaukka, T., Vuopio-Varkila, J., Muotiala, A., Helenius, H., Lager, K. et al. (1997). The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. New England Journal of Medicine 337, 441-6.
14. Kernbaum, S. (1982). La spiramycine. Utilisation en thérapeutique humaine. Semaine des Hospitaux 58, 289-97.
15. Wenzel, R. P., Hendley, J. O., Dodd, W. K. & Gwaltney, J. M. (1976). Comparison of josamycin and erythromycin in the therapy of Mycoplasma pneumoniae pneumonia. Antimicrobial Agents and Chemotherapy 10, 899-901.
16. Fraschini, F. (1990). Clinical efficacy and tolerance of two new macrolides, clarithromycin and josamycin, in the treatment of patients with acute exacerbations of chronic bronchitis. Journal of International Medical Research 18, 171-6.
17. Marchant, C. D. (1990). Spectrum of disease due to Branhamella catarrhalis in children with particular reference to acute otitis media. American Journal of Medicine 88, Suppl. 5A, S15-9.
18. Wald, E. R., Milmoe, G. J., Bowen, A., Ledesma-Medina, J., Salamon, N. & Bluestone, C. D. (1981). Acute maxillary sinusitis in children. New England Journal of Medicine 304, 749-54.
19. Kaleida, P. H., Casselbrant, M. L., Rockette, H. E., Paradise, J. L., Bluestone, C. D., Blatter, M. M. et al. (1991). Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Pediatrics 87, 466-74.
20. Marchant, C. D., Carlin, S. A., Johnson, C. E. & Shurin, P. A. (1992). Measuring the comparative efficacy of antibacterial agents for acute otitis media: the 'Pollyanna phenomenon'. Journal of Pediatrics 120, 72-7.
21. Niederman, M. S., Bass, J. B., Campbell, G. D., Fein, A. M., Grossman, R. F., Mandell, L. A. et al. (1993). Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Review of Respiratory Disease 148, 1418-26.
22. Mandell, L. A., Niederman, M. S. & The Canadian Community Acquired Pneumonia Consensus Conference Group. (1993). Antimicrobial treatment of community acquired pneumonia in adults: a conference report. Canadian Journal of Infectious Diseases 4, 25-8.
23. British Thoracic Society. (1993). Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. British Journal of Hospital Medicine 49, 346-50.
24. Klugman, K. P. (1994). Management of antibiotic-resistant pneumococcal infections. Journal of Antimicrobial Chemotherapy 34, 191-3.
25. Sanchez, C., Armengol, R., Lite, J., Mir, I. & Garau, J. (1992). Penicillin-resistant pneumococci and community-acquired pneumonia. Lancet 339, 988.
26. Soussy, C. J., Cluzel, R., Courvalin, P. & the Comité de l'Antibiogramme de la Société Française de Microbiologie. (1994). Definition and determination of in vitro antibiotic susceptibility breakpoints for bacteria in France. European Journal of Clinical Microbiology and Infectious Diseases 13, 238-46.